Слайд 1 - Industrial Technologies 2012

Download Report

Transcript Слайд 1 - Industrial Technologies 2012

Commercialization of nanotechnologies
in Russia promoted by RUSNANO
Prof. Sergey Kalyuzhnyi, Head of Department of Scientific &
Technical Expertise, Member of the Executive Board
 RUSNANO: Facts and Figures
Stock Company RUSNANO – fabrication of
nanoproducts
Russian Corporation
of Nanotechnologies
Non-profit foundation – infrastructure,
education etc.
2007 – 2010
2011 – 2015
…
Mission: to implement the state policy
in the field of nanotechnology
Key tasks: commercialization of
nanotechnology projects, modernization
of Russian industry, “smart jobs” creation
RF asset contributions: € 3.2 bln
Guaranteed debt financing: € 4.3 bln
Aarhus, Denmark, 18-21 Jun 2012
Sergey Kalyuzhnyi
2
 RUSNANO & Russian nanoindustry
Russian nanoindustry
RUSNANO Group of Companies
Independent
“nano”
companies
RUSNANO holding
Project
companies
Stock
Company
RUSNANO
Metrological
Center
Venture
funds
Research
institutes
and
universities
Nanocenters &
incubators
Aarhus, Denmark, 18-21 Jun 2012
RUSNANO
subsidiaries
Non-profit
foundations
(educational
programs,
conferences,
infrastructure)
Sergey Kalyuzhnyi
RUSNANOInform
RUSNANO USA, Inc.
RUSNANO Israel Ltd.
RUSNANO Capital AG
3
 Nanoindustry development
Legal basis
development
Standardization/
certification
Infrastructure
Motivation
to research
International Forum on
Nanotechnologies
31.10-03.11.2012
NANOINDUSTRY
Popularization
& Education
Demand
promotion
Motivation to
be technically
competent
Increase in
demand
Investment
projects
Aarhus, Denmark, 18-21 Jun 2012
Sergey Kalyuzhnyi
4
 Russian Nanoindustry: Key Goals
25
Revenue, € bln
20
total revenue of
nano-enabled
products
15
revenue of nanoenabled products
of RUSNANO
project companies
10
5
0
2009
2010
2011
2012
2013
2014
2015
Annual revenue of nanoindustry (2015): € 22,5 bln
Employment in nanoindustry (2015): up to 150 000 persons
Aarhus, Denmark, 18-21 Jun 2012
Sergey Kalyuzhnyi
5
 RUSNANO projects statistics*
Total applications :
2402
Approved by Scientific
Council:
275
Approved by the
Board of Directors:
116 (+23**)
Under financing:
86 (+14***)
* as of 25th of May, 2012
** 12 venture funds and 11
nanotechnological centers;
*** 7 venture funds and
nanotechnological centers;
7
Infrastructure projects (besides
nanotechnological centers) - 5
Educational programs - 63
* as of 18th of June, 2012
Aarhus, Denmark, 18-21 Jun 2012
Sergey Kalyuzhnyi
6
 RUSNANO projects conveyer*
Approved to be financed:
139 projects for €14.6 bln
including €6.1 bln of RUSNANO investments
42%
58%
The rest €8.5 bln is from other
co-investors
* as of 18th of June, 2012
Aarhus, Denmark, 18-21 Jun 2012
Sergey Kalyuzhnyi
7
 RUSNANO projects under financing*
 Molecular Diagnostics
 Clinical Diagnostics
 Therapy
 Surgery
15
Medicine
&
Pharmace
uticals
 Physical methods
 Chemical methods
 Electrochemical
methods
 Bulk coatings
12
Coatings &
surface
modificatio
n
Composite
materials
24
 Metals and alloys
 Ceramic materials
 Semiconductor materials
 Carbon materials
 Polymer materials
 Composites
8
 Energy production
 Energy storage
 Energy saving
 Energy usage
Energy
efficiency
& Clean
Tech.
Optics &
Electronics
17
 Optoelectronics
 Microelectronics
 Power/SHF
electronics
Other
10
 Equipment
 Services
 Raw materials
* as of 13th of June, 2012
Aarhus, Denmark, 18-21 Jun 2012
Sergey Kalyuzhnyi
8
 Projects with a foreign participation by country*
Total applications (367)
Applications from EC (total 108)
Singapore
Taiwan
Australia
China
Japan
India
South…
Canada
Israel
CIS
Europe
USA
0
50
100
150
200
Projects under financing (total 29)
Netherlands
initiated by
Switzerland
co-invested by
France
Finland
Israel
China
Italy
Great Britain
Germany
USA
0
Aarhus, Denmark, 18-21 Jun 2012
5
Sergey Kalyuzhnyi
10
15
20
*
as of 18th of June, 2012
9
 Financed projects with foreign participation*
 Bind
 Selecta
 Domain
…
 Thunder Sky
 Joule
…
3
8
Medicine &
Pharmaceu
ticals
Energy
efficiency
& Clean
Tech.

 Rosbeneq
 Galileo
 SDN technology
…
4
Coatings &
surface
modificatio
n
Composite
materials
1
 Pilkington
Aarhus, Denmark, 18-21 Jun 2012
Sergey Kalyuzhnyi
Optics &
Electronics
11
Plastic logic
 MRAM
 ALOX
 Oerlikon
…
Other
0
* as of 18th of June, 2012
10
 New plants commissioned in 2010-2012
Novomoskovsk,
Tula region
1. “Germanium”
Karachev,
Bryansk region
1. “Metaclay”
St. Petersburg
1. “Optosens”
2. “Connector Optics”
3. “Virial”
4. “Optogan”
5. “RFID”
Moscow and Moscow
region
1. “Center of prospective
technologies”
2. “Nanoteh-Dubna”
3. HC “Komposit”
4. “Sintronics-Nano”
Vladimir
1. «ALOX»
Nizhniy Novgorod
1. “RMT”
2. “Plakart”
Rybinsk,
Yaroslavl
region
1. “New
instrumental
solutions”
Izhevsk
1. “NPC Pruzhina”
Ekaterinburg
1. “Uralplastic-N”
Kazan
1. “Danaflex-Nano”
Ufa
1. “ESM”
Novosibirsk
1. “Thunder Sky”
Total: 20 plants
Aarhus, Denmark, 18-21 Jun 2012
Sergey Kalyuzhnyi
11
 Establishing of fiber lasers industry in Russia
 IPG Photonics, USA + Germany
World lasers market forecast, € bln
10
Industrial and automotive
Computing and entertainment
Telecommunications
Medicine
Others
9
8
7
6
5
4
3
 Development and manufacturing
of high-performance fiber lasers
and amplifiers
2
1
0
2009
Advantages:
2010
2011
2016
Application areas segmentation (2010)
High-performance
Diverse applications
29%
Investment, € mln
 Total: 137
 RUSNANO: 39
Computing and entertainment
Telecommunications
14%
Medicine
Site: Fryasino, Moscow region
Project company: IRE-Polus
Aarhus, Denmark, 18-21 Jun 2012
Industrial and automotive
16%
Sergey Kalyuzhnyi
19%
22%
Others
*Source: BCC Research 2011
12
 Ultrahigh speed optical interconnects
 VI Systems GmbH, Germany
 Epitaxial wafers and chips of emitters/
detectors for ultrahigh speed optical
interconnects
 Applications in local and storage area
networks, wireless and other markets
Advantages:
Speed ˃ 40 Gb/s, 4 times higher than
competitors
Thermal stability
Energy efficiency
Vertical Cavity Surface Emitting Laser
(VCSEL) with electro-optical modulator
Investment, € mln
 Total: 27
 RUSNANO: 19
GaAs wafer
Chip
End products
Components
Modules
Site: St. Petersburg
Project company: Connector optics
Aarhus, Denmark, 18-21 Jun 2012
Sergey Kalyuzhnyi
13
 Magnetoresistive memory TAS-MRAM 90nm/65nm
 Crocus Technology, France + USA, Israel
 The memory device with random
access, which stores information
using magnetic moments rather
than electric charges.
Advantages:
non-volatile memory
faster than Flash
data density comparable to
DRAM
Investment, € mln
 Total: 264
 RUSNANO: 95
Semiconductor memory market,
€ bln
60
80
70
60
45
50
40
30
30
20
15
10
0
Site: Zelenograd, Moscow region
*Source: Samsung, iSuppli Corp., Electronics.ca Publications
Aarhus, Denmark, 18-21 Jun 2012
Sergey Kalyuzhnyi
14
 Equipment for thin films and coatings production
 Beneq Oy, Finland
 Equipment for atomic layer
deposition ALD and aerosol coating
nAERO®/nHALO®
 To be used in solar photovoltaic,
flexible electronics and
strengthened glass production etc.
Advantages:
Potential market of technology, € mln.
World leader in ALD-equipment
300
250
80
Suitable for industrial production
200
High yield technologies
58
44
150
100
Investment, € mln
 Total: 28
 RUSNANO: 25
33
133
50
-
Lab: Saint Petersburg
25
11
7
2010
15
13
29
2011
2012
ALD
166
197
70
2013
2014
2015
2016
Aerosol
Аэрозоль
*Source: Company data
Aarhus, Denmark, 18-21 Jun 2012
Sergey Kalyuzhnyi
15
 Pilkington glass
 Pilkington Group Ltd, Great Britain
Scheme of operation
Advantages:
– Warm
weather
Reducing the heat losss through
window for 70%
– Cold
weather
Cost of final products with energysaving glass is only 10% higher than
that of ordinary glass
Glass market dynamics, € bln
2250

Energy-efficient glass (low
emissivity and solar control
glass)
1850
1500
925
2250
750
Investment, € mln
 Total: 740
 RUSNANO: 185
Site: Ramenskoe, Moscow region
Project company: Pilkington Glass
Low-e glass
Ordinary glass
*Source: Branan 2010
Aarhus, Denmark, 18-21 Jun 2012
Sergey Kalyuzhnyi
16
 Electrochemical Energy Storage Devices

Thunder Sky Energy Group Limited, China
Thunder Sky
Russian Plant and R&D
Centre
Investment, € mln
 Total: 339
 RUSNANO: 190
Site: Novosibirsk
Project company: Liotech
*Source: Johnson Control – SAFT 2005&2007
Advantages:
High energy capacity (600 Ah for electric transport)
No memory effect after numerous charge-discharge cycles
Charging with high-ampere current (20 minutes up to 70% of capacity)
Wide temperature range of exploitation from -45°C to +65°C
Low cost and safety of production
Aarhus, Denmark, 18-21 Jun 2012
Sergey Kalyuzhnyi
17
 Targeted polymeric drug delivery
 BIND Biosciences Inc., USA
50-150
nm
targeting ligand
 Combinatorial libraries of drugencapsulated nanoparticles
stealth and
protective layer
 Biodegradable PLA-PEG block copolymers
polymer matrix
 Self-assembling nanoparticles with
unmodified API
active
pharmaceutical
ingredient (API)
Advantages:
Current stage:
Bind-014 (docetaxel targeted to PSMA)
Phase I clinical trials (cancer patients)
Optimal drug release profile
Near future further development for:
High drug concentration in tumor tissue
 Oncology
 Cardiovascular disorders
 Inflammatory diseases
Investment, € mln
 Total: 147 / RUSNANO: 19
Lab: Moscow region
Aarhus, Denmark, 18-21 Jun 2012
Cell/tissue specific targeting



long circulating half-life
immune system evasion
dual targeting mechanism
Reduced side effects
Broad range of APIs
Reproducible and scalable manufacturing
Sergey Kalyuzhnyi
18
 Polymeric nanoparticles for vaccine development
 Selecta Biosciences Inc., USA
antigen
T-help antigen
adjuvant
150-250
nm
matrix
PEG
 Targeted Synthetic Vaccine Particle
tSVP
 Biodegradable self-assembling
synthetic polymers
 Full integration of antigens and
adjuvants
Advantages:
Current stage:
Fully synthetic vaccines
Sel-068 (treatment of smoking addiction)
Phase I clinical trials (Q4 2011)
Rational design

optimal size for immune system
recognition

antigen/adjuvant composition for
optimal immunogenicity
Investment, € mln
 Total: 121 / RUSNANO: 19

controlled antigen/adjuvant
release
Lab: Moscow region

humoral and/or cellular immune
response
Near future further development for:
 Oncology
 Infectious diseases
Aarhus, Denmark, 18-21 Jun 2012
Sergey Kalyuzhnyi
19
 PUSNANO invites:

Technology owners to relocate their production/R&D business
in Russia

Strategic or financial investors to participate in Russia-based
projects
Thank you for attention!
Prof. Sergey V. Kalyuzhnyi,
Department of Scientific and technical Expertise,
Member of the Board of Directors
RUSNANO
www.rusnano.com
[email protected]
Aarhus, Denmark, 18-21 Jun 2012
Sergey Kalyuzhnyi
20